NE
NexgenRx Inc.
NEGXF · OTC
$0.46 +6.35% (+$0.03)
1M +948.78%
Market Cap $45.2M
P/E Ratio 17.14x
Div. Yield 3.19%
ROE 30.87%
Bulios Fair Price
$0.63
37.8% upside
Trenutna cena
$0.46
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica NEGXF trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
3/9Valuation
80 /100
Cheap P/B 4.81x
P/S 2.37x
P/E 17.14x
Growth
59 /100
Stable Book val. growth 4.61%
Rev. growth 11.90%
FCF growth N/A
Profitability
59 /100
Moderate FCF margin 8.95%
Op. margin 18.11%
Gross margin 79.94%
Quality
84 /100
Excellent Asset turnover 0.41x
ROA 5.73%
ROIC 28.63%
Debt
92 /100
Low Net debt/EBITDA -8.47x
Int. coverage 19.97x
Debt/Equity 0.03x
Stability
54 /100
Moderate Profitable years 2
EPS volatility 1,061.97%
Beta 0.49x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o NEGXF
Online
Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Ronald C. Loucks
Employees
20
Headquarters
Toronto